QIAGEN N.V. (QGEN): Here Are Some Research Recommendations

QIAGEN N.V. (NYSE:QGEN) finished Friday with an addition of $0.43 to close at $53.99, an upside of 0.80 percent. An average of 310,920 shares of common stock have been traded in the last five days. There was a gain of $2.35 in the past week, and it reached a new high 16 times over the past 12 months. The last 20 days have seen an average of 589,345 shares traded, while the 50-day average volume stands at 618,760.

QGEN stock has decreased by -1.53% in the last month. The company shares reached their 1-month lowest point of $50.08 on 10/01/21. With the stock rallying to its 52-week high on 02/08/21, shares of the company touched a low of $45.33 and a high of $59.00 in 52 weeks. It has reached a new high 9 times so far this year and achieved 2.16% or $1.14 in price. In spite of this, the price is down -8.49% from the 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Valuation Metrics

QIAGEN N.V. (QGEN) has a trailing price-to-earnings (P/E) ratio of 26.26, which compares with the 26.50 for the broader industry and 33.43 for the sector. In the last five years, QIAGEN N.V.’s PE ratio has ranged between 1747.33 and 22.60. The stock’s beta is 0.21. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 5.71, the price-to-book (PB) ratio at 4.14, and the price-to-cash flow ratio at 29.80.

The quick ratio of QIAGEN N.V. for the three months ended June 29 was 2.90, and the current ratio was 3.60, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.65 and a total debt to equity ratio of 0.65 for the quarter ending June 29. QIAGEN N.V.’s EBITDA margin for the year ending June 29 is 38.46%, while its operating margin for the same period stands at 24.00%. Its gross profit as reported stood at $1.23 billion compared to revenue of $1.87 billion.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, QIAGEN N.V.’s return on assets was 8.20%. For the broader industry, ROE averaged -2.89 over the past year.

Earnings Surprise

For the three-month period that ended June 29, QIAGEN N.V. had $129.59 million in cash and short-term investments compared to $1.42 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$41.46 million in the quarter, while revenues were grew 559.19%. The analyst consensus anticipated QIAGEN N.V.’s latest quarter earnings to come in at $0.65 per share, but it turned out to be $0.67, a 3.10% surprise. For the quarter, EBITDA amounted to $224.4 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at QIAGEN N.V. (QGEN) price momentum. RSI 9-day as of the close on 22 October was 74.74%, suggesting the stock is Overbought, with historical volatility in this time frame at 3.54%.

As of today, QGEN’s price is $53.08 +4.55% or $2.35 from its 5-day moving average. QGEN is currently trading -0.26% lower than its 20-day SMA and +14.73% higher than its 100-day SMA. However, the stock’s current price level is +5.70% above the SMA50 and +2.33% above the SMA200.

The stochastic %K and %D were 93.84% and 94.16%, respectively, and the average true range (ATR) was 0.74. With the 14-day stochastic at 93.62% and the average true range at 0.78, the RSI (14) stands at 64.11%. The stock has reached 1.22 on the 9-day MACD Oscillator while the 14-day reading was at 1.71.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Hot Topics

Related Videos

Related Videos

Related Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

592

100% free. stop anytime no spam